Two federal judges with  seemingly opposite rulings on whether using GenAI tools waives the work product privilege. But the cases present facts that differ in important ways.

Here’s what reading them together can tell us about discovery risk, waiver, and pro se status. The bottom line is that privilege issues can still be minefield, and neither ruling necessarily gives you a safe harbor.

Here’s my post for Above the Law.